Clinical Trial Update: Convalescent Plasma in the Treatment of COVID 19 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating convalescent plasma for treatment of COVID-19, completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syndrome Coronavirus 2

Drugs mentioned

• Convalescent Plasma (convalescent plasma)

Snippet

Sponsor: Trinity Health Of New England | Conditions: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), COVID | Phase 2 | Status: COMPLETED | Results posted: 2020-09-17